Guillain-Barré syndrome
Title Filter     Display # 
# Article Title
1 Emerging drugs for Guillain-Barre syndrome.
2 Plasma exchange after initial intravenous immunoglobulin treatment in guillain-barré syndrome: critical reassessment of effectiveness and cost-efficiency.
3 [Current use of immunoglobulins in neurology :]
4 Prominent plasmacytosis following intravenous immunoglobulin correlates with clinical improvement in
5 [High-dose intravenous immunoglobulins for treatment of optic neuritis in Guillain-Barré syndrome]
6 Motor recovery after Guillain-Barré syndrome in childhood.
7 Pharmacoeconomics of therapy for Guillain-Barre syndrome: plasma exchange and intravenous immunoglob
8 Guidelines on the use of intravenous immune globulin for neurologic conditions.
9 Treatment for Fisher syndrome, Bickerstaff's brainstem encephalitis and related disorders.
10 Drug Insight: the use of intravenous immunoglobulin in neurology-therapeutic considerations and prac
11 Guillain-Barre syndrome.
12 Current therapeutic options in severe Guillain-Barre syndrome.
13 Current therapeutic options in severe guillain-barre syndrome.
14 [High doses of immunoglobulin G in the therapy for severe forms of myasthenia gravis and Guillain-Ba
15 Guillain-Barre syndrome in the elderly: clinical, electrophysiological, therapeutic and outcome feat
16 Posttransplant guillain barre syndrome
17 [Present treatment of Guillain-Barre syndrome]
18 Use of IV immunoglobulins in neurology. Evidence-based consensus
19 Immunoglobulin improves a model of acute motor axonal neuropathy by preventing axonal degeneration.
20 Treatment of inflammatory and paraproteinemic neuropathies.
 
<< Start < Prev 1 2 Next > End >>
Page 1 of 2